MADEMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MADEMED
Largest movements
- Receivables within one year -€150,078
down €150,078 (-99.3%), from €151,111 to €1,033
of which Trade receivables: -€150,104
- Other debts -€145,037
down €145,037 (-96.8%), from €149,814 to €4,777
- Profit (loss) carried forward -€5,510
down €5,510 (-112%), from -€4,903 to -€10,413
- Gross operating margin -€4,840
new in 2025: -€4,840
- Other operating charges +€179
up €179 (+39.5%), from €453 to €632
- Financial charges -€105
down €105 (-73.4%), from €143 to €38
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €151,111 | €1,386 | -€149,725 | -99.1% |
| Current assets | 29/58 | €151,111 | €1,386 | -€149,725 | -99.1% |
| Amounts receivable within one year | 40/41 | €151,111 | €1,033 | -€150,078 | -99.3% |
| Trade receivables | 40 | €150,104 | - | -€150,104 | |
| Other amounts receivable | 41 | €1,007 | €1,033 | +€26 | +2.6% |
| Cash at bank and in hand | 54/58 | - | €353 | +€353 | |
| Total equity and liabilities | 10/49 | €151,111 | €1,386 | -€149,725 | -99.1% |
| Equity | 10/15 | €1,297 | -€4,213 | -€5,510 | |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€4,903 | -€10,413 | -€5,510 | -112% |
| Amounts payable | 17/49 | €149,814 | €5,599 | -€144,215 | -96.3% |
| Amounts payable within one year | 42/48 | €149,814 | €5,599 | -€144,215 | -96.3% |
| Trade debts | 44 | - | €822 | +€822 | |
| Suppliers | 440/4 | - | €822 | +€822 | |
| Other amounts payable | 47/48 | €149,814 | €4,777 | -€145,037 | -96.8% |
| Other operating charges | 640/8 | €453 | €632 | +€179 | +39.5% |
| Gross operating margin | 9900 | - | -€4,840 | -€4,840 | |
| Operating profit (loss) | 9901 | -€453 | -€5,472 | -€5,019 | -1,108% |
| Financial income | 75/76B | €17 | - | -€17 | |
| Recurring financial income | 75 | €17 | - | -€17 | |
| Financial charges | 65/66B | €143 | €38 | -€105 | -73.4% |
| Recurring financial charges | 65 | €143 | €38 | -€105 | -73.4% |
| Profit (loss) for the period before taxes | 9903 | -€579 | -€5,510 | -€4,931 | -852% |
| Profit (loss) for the period | 9904 | -€579 | -€5,510 | -€4,931 | -852% |
| Profit (loss) for the period to be appropriated | 9905 | -€579 | -€5,510 | -€4,931 | -852% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.